"We're Giving You Something So We Get Something in Return": Perspectives on Research Participation and Compensation Among People Living with HIV Who Use Drugs

Overview

Journal Int J Drug Policy

Publisher Elsevier

Specialties Psychiatry
Public Health

Date 2016 Oct 26

PMID 27780116

Citations 17

Authors

Alexandra B Collins

Carol Strike

Adrian Guta

Rosalind Baltzer Turje

Patrick McDougall

Surita Parashar

Ryan McNeil

Affiliations

Soon will be listed here.

Abstract

Background: Compensation for participating in research has been a fundamental element of the research apparatus despite concerns about its impact on incentivising participation. Researchers and research ethics boards acknowledge that compensation may prompt structurally vulnerable populations, such as people who use drugs (PWUD), to engage in research primarily out of financial need. Thus, institutional restrictions around compensation have been implemented. This study explores the ethical implications of compensation practices aimed at 'protecting' structurally vulnerable people living with HIV (PLHIV) who use drugs within the context of individuals' lived realities.

Methods: We draw on five focus groups conducted in 2011 with 25 PLHIV who use drugs and access a community-based HIV care facility in Vancouver, Canada. This analysis focused on participants' perceptions of research compensation, which became the central point of discussion in each group.

Results: Participants viewed research as a transactional process through which they could challenge the underpinnings of bioethics and bargain for compensation. Research compensation was thus critical to attracting participants and positioned as a 'legitimate' form of income. Participants' medicalised identities, specifically living with HIV, were fundamental to justifying compensation. The type of compensation (e.g. gift card, cash) also significantly impacted whether participants were fully compensated and, at times, served to exacerbate their structural vulnerability.

Conclusion: Research compensation is critical in shaping structurally vulnerable populations' participation and experiences with research and can further marginalize individuals. Practices surrounding research compensation, particularly for drug-using and HIV-positive populations, need to be evaluated to ensure participants are equitably compensated for the expertise they provide.

Citing Articles

Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.

Bardwell G, Bowles J, Mansoor M, Werb D, Kerr T Subst Abuse Treat Prev Policy. 2023; 18(1):14.

PMID: 36869358 PMC: 9984129. DOI: 10.1186/s13011-023-00525-2.

Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol.

Salvalaggio G, Ferguson L, Brooks H, Campbell S, Gladue V, Hyshka E Syst Rev. 2022; 11(1):66.

PMID: 35418306 PMC: 9008896. DOI: 10.1186/s13643-022-01938-z.

What are the ethical implications of using prize-based contingency management in substance use? A scoping review.

Gagnon M, Payne A, Guta A Harm Reduct J. 2021; 18(1):82.

PMID: 34348710 PMC: 8335458. DOI: 10.1186/s12954-021-00529-w.

"He's under oath": Privacy and Confidentiality Views Among People Who Inject Drugs Enrolled in a Study of Social Networks and Human Immunodeficiency Virus/Hepatitis C Virus Risk.

Abadie R, Fisher C, Dombrowski K J Empir Res Hum Res Ethics. 2021; 16(3):304-311.

PMID: 33769904 PMC: 8260099. DOI: 10.1177/15562646211004411.

Designing and implementing an intervention for returning citizens living with substance use disorder: discovering the benefits of peer recovery coach involvement in pilot clinical trial decision-making.

Victor G, Sightes E, Watson D, Ray B, Bailey K, Robision L J Offender Rehabil. 2021; 60(2):138-158.

PMID: 33551628 PMC: 7861566. DOI: 10.1080/10509674.2020.1863301.

References

Rudy E, Estok P, Kerr M, Menzel L . Research incentives: money versus gifts. Nurs Res. 1994; 43(4):253-5. DOI: 10.1097/00006199-199407000-00012. View

Benatar D . Bioethics and health and human rights: a critical view. J Med Ethics. 2005; 32(1):17-20. PMC: 2563274. DOI: 10.1136/jme.2005.011775. View

Grady C . Money for research participation: does in jeopardize informed consent?. Am J Bioeth. 2002; 1(2):40-4. DOI: 10.1162/152651601300169031. View

Barratt M, Norman J, Fry C . Positive and negative aspects of participation in illicit drug research: implications for recruitment and ethical conduct. Int J Drug Policy. 2007; 18(3):235-8. DOI: 10.1016/j.drugpo.2006.07.001. View

Quesada J, Hart L, Bourgois P . Structural vulnerability and health: Latino migrant laborers in the United States. Med Anthropol. 2011; 30(4):339-62. PMC: 3146033. DOI: 10.1080/01459740.2011.576725. View

Pandya M, Desai C . Compensation in clinical research: The debate continues. Perspect Clin Res. 2013; 4(1):70-4. PMC: 3601710. DOI: 10.4103/2229-3485.106394. View

Farre M, Lamas X, Cami J . Sensation seeking amongst healthy volunteers participating in phase I clinical trials. Br J Clin Pharmacol. 1995; 39(4):405-9. PMC: 1365128. DOI: 10.1111/j.1365-2125.1995.tb04469.x. View

Festinger D, Marlowe D, Croft J, Dugosh K, Mastro N, Lee P . Do research payments precipitate drug use or coerce participation?. Drug Alcohol Depend. 2005; 78(3):275-81. DOI: 10.1016/j.drugalcdep.2004.11.011. View

Hedgecoe A . Critical bioethics: beyond the social science critique of applied ethics. Bioethics. 2004; 18(2):120-143. DOI: 10.1111/j.1467-8519.2004.00385.x. View

10.

Fry C, Dwyer R . For love or money? An exploratory study of why injecting drug users participate in research. Addiction. 2001; 96(9):1319-25. DOI: 10.1046/j.1360-0443.2001.969131911.x. View

11.

McKeganey N . To pay or not to pay: respondents' motivation for participating in research. Addiction. 2001; 96(9):1237-8. DOI: 10.1046/j.1360-0443.2001.96912371.x. View

12.

Fry C, Hall W, Ritter A, Jenkinson R . The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics. 2009; 1(4):21-36. DOI: 10.1525/jer.2006.1.4.21. View

13.

Reiser S . Research compensation and the monetarization of medicine. JAMA. 2005; 293(5):613-4. DOI: 10.1001/jama.293.5.613. View

14.

Viruell-Fuentes E, Miranda P, Abdulrahim S . More than culture: structural racism, intersectionality theory, and immigrant health. Soc Sci Med. 2012; 75(12):2099-106. DOI: 10.1016/j.socscimed.2011.12.037. View

15.

Ripley E, Macrina F, Markowitz M, Gennings C . Why do we pay? A national survey of investigators and IRB chairpersons. J Empir Res Hum Res Ethics. 2010; 5(3):43-56. PMC: 3168552. DOI: 10.1525/jer.2010.5.3.43. View

16.

Macklin R . On paying money to research subjects: 'due' and 'undue' inducements. IRB. 1981; 3(5):1-6. View

17.

Russell M, Moralejo D, Burgess E . Paying research subjects: participants' perspectives. J Med Ethics. 2000; 26(2):126-30. PMC: 1733207. DOI: 10.1136/jme.26.2.126. View

18.

Dickert N, Grady C . What's the price of a research subject? Approaches to payment for research participation. N Engl J Med. 1999; 341(3):198-203. DOI: 10.1056/NEJM199907153410312. View

19.

McNeil R, Kerr T, Anderson S, Maher L, Keewatin C, Milloy M . Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Soc Sci Med. 2015; 133:168-76. PMC: 4423784. DOI: 10.1016/j.socscimed.2015.04.008. View

20.

Permuth-Wey J, Borenstein A . Financial remuneration for clinical and behavioral research participation: ethical and practical considerations. Ann Epidemiol. 2009; 19(4):280-5. DOI: 10.1016/j.annepidem.2009.01.004. View